Amarin Corp Plc (AMRN)

[HDGabor]

JL-

Judge Du did say that the generics should be careful in their marketing and actions less they be inducing infringement on Amarin's Non Marine patents which she did not invalidate

Where / when? I am not aware of a single document that contains anything similar to this ...

We had a great deal of discussion on this subject on this very board.

I do not remember for a single post - other than yours - that say it (Judge Du did say) ...

This included some remarks one of the companies (Hikma I think) made at an investor conference that suggested patient numbers that were considerably higher than the totals for the Marine indications..And this was thought to suggest H was aiming for more than the MARINE population..

(i) it was not patient numbers but revemue
(ii) it was not calculated by Hikma but by IQVIA
(iii) it was exactly the MARINE indication (calculated Gross Revenue ... based on WSP and dispensed scripts)
(iv) it was not about Hikma expected revenue but the actual (past 12 months) revenue of Amarin ... the targeted market

It was clarified several times ...

Best,
G